COVID-19 aus Sicht der Pneumologie – Langzeitfolgen und Implikationen für die pneumologische Nachsorge

Abstract

The long-term sequelae of COVID-19 on are not yet predictable. Radiological and histopathological data on COVID-19 and observational studies after the SARS-CoV-1 pandemic 2003/2004 suggest that in a proportion of COVID-19 patients, functional limitations due to pulmonary fibrosis and other patterns of lung damage may persist. Systematic follow-up, based on prudent pulmonary function testing, is warranted for the correct diagnosis, graduation and treatment of the underlying pathology at an early stage. This review summarizes the potential spectrum of Post-COVID-19 pulmonary disease patterns and provides recommendations for the follow-up care of COVID-19 patients in the field of respiratory medicine.

Die pulmonalen Langzeitfolgen von COVID-19 sind noch nicht absehbar. Bisherige Daten zur aktuellen und zur damaligen (SARS-CoV-1-) Pandemie legen nahe, dass nach überstandener Akutphase der Erkrankung bei einem Teil der Patienten pulmonale Schäden persistieren werden. Um Langzeitauswirkungen frühzeitig erkennen, klassifizieren und behandeln zu können, ist eine pneumologische Nachsorge der betroffenen Patienten erforderlich.

Schlüsselwörter

Langzeitfolgen - Lungenfibrose - radiologische Befunde - systematisches Follow-up - diffuser Alveolarschaden

Key words

long-term sequelae - pulmonary fibrosis - radiological data - systematic follow-up - diffuse alveolar damage

Publikationsverlauf

Artikel online veröffentlicht:
30. Juli 2020

• Literatur

• 1 Huang C, Wang Y, Li X. et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 2020; 395: 497-506 . doi:10.1016/S0140-6736(20)30183-5
• 2 Wang D, Hu B, Hu C. et al Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. Jama 2020; 323: 1061-1069 . doi:10.1001/jama.2020.1585
• 3 Ständiger Arbeitskreis der Kompetenz- und Behandlungszentren für Krankheiten durch hochpathogene Erreger am Robert Koch-Institut (STAKOB). Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19, Stand: 10.06.2020. Im Internet (Stand 12.06.2020): www.rki/de/covid-19-therapie-stakob
• 4 Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. Jama 2020;
• 5 Tay MZ, Poh CM, Rénia L. et al The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;
• 6 Wichmann D, Sperhake JP, Lütgehetmann M. et al Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann Internal Med 2020;
• 7 Vogel-Claussen J, Ley-Zaporozhan J, Agarwal P. et al Recommendations of the Thoracic Imaging Section of the German Radiological Society for clinical application of chest imaging and structured CT reporting in the COVID-19 pandemic. Rofo 2020;
• 8 Song F, Shi N, Shan F. et al Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology 2020; 295: 210-217 . doi:10.1148/radiol.2020200274
• 9 Ye Z, Zhang Y, Wang Y. et al Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol 2020;
• 10 Shi H, Han X, Jiang N. et al Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020; 20: 425-434 . doi:10.1016/S1473-3099(20)30086-4
• 11 Kong W, Agarwal PP. Chest Imaging Appearance of COVID-19 Infection. Radiol Cardiothor Imag 2020; 2: e200028 . doi:10.1148/ryct.2020200028
• 12 Wormanns D, Biederer J, Rehbock B. Thoraxdiagnostik. Stuttgart: Thieme; 2016
• 13 Tian S, Xiong Y, Liu H. et al Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 2020;
• 14 Cheung OY, Chan JWM, Ng CK. et al The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology 2004; 45: 119-124 . doi:10.1111/j.1365-2559.2004.01926.x
• 15 Hwang DM, Chamberlain DW, Poutanen SM. et al Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 2005; 18: 1-10 . doi:10.1038/modpathol.3800247
• 16 Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res 2017; 143: 142-150 . doi:10.1016/j.antiviral.2017.03.022
• 17 Zuo W, Zhao X, Chen YG. SARS Coronavirus and Lung Fibrosis. In: Lal SK. Hrsg Molecular Biology of the SARS-Coronavirus. Berlin, Heidelberg: Springer; 2010: 247-258
• 18 Hosseiny M, Kooraki S, Gholamrezanezhad A. et al Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. Am J Roentgenol 2020; 214: 1078-1082 . doi:10.2214/ajr.20.22969
• 19 Antonio GE, Wong KT, Hui DS. et al Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology 2003; 228: 810-815 . doi:10.1148/radiol.2283030726
• 20 Hsu HH, Tzao C, Wu CP. et al Correlation of high-resolution CT, symptoms, and pulmonary function in patients during recovery from severe acute respiratory syndrome. Chest 2004; 126: 149-158 . doi:10.1378/chest.126.1.149
• 21 Hui DS, Wong KT, Antonio GE. et al Long-term sequelae of SARS: physical, neuropsychiatric, and quality-of-life assessment. Hong Kong Med J 2009; 15 (Suppl. 08) 21-23
• 22 Ng CK, Chan JW, Kwan TL. et al Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. Thorax 2004; 59: 889-891 . doi:10.1136/thx.2004.023762
• 23 Wu X, Dong D, Ma D. Thin-Section Computed Tomography Manifestations During Convalescence and Long-Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS). Int Med J Exp Clin Res 2016; 22: 2793-2799 . doi:10.12659/msm.896985
• 24 Xie L, Liu Y, Fan B. et al Dynamic changes of serum SARS-Coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir Res 2005; 6: 5 . doi:10.1186/1465-9921-6-5
• 25 Chang YC, Yu CJ, Chang SC. et al Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology 2005; 236: 1067-1075 . doi:10.1148/radiol.2363040958
• 26 Ong KC, Ng AW, Lee LS. et al 1-year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest 2005; 128: 1393-1400 . doi:10.1378/chest.128.3.1393
• 27 Lam MH, Wing YK, Yu MW. et al Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Internal Med 2009; 169: 2142-2147 . doi:10.1001/archinternmed.2009.384
• 28 Dreher M, Kersten A, Bickenbach J. et al Charakteristik von 50 hospitalisierten COVID-19-Patienten mit und ohne ARDS. Dtsch Arztebl Int 2020; 117: 271-278 . doi:10.3238/arztebl.2020.0271